Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways

Fig. 1

Susceptibility of mesothelioma and immortalized mesothelial cells to metformin. a Cells were treated with metformin at various concentrations for 4 days and the cell viabilities were measured with the WST assay. Relative viability was calculated based on untreated cells. IC50 values were calculated with CalcuSyn software. b Cells were treated with metformin as indicated and the live cell numbers were counted with a trypan blue dye exclusion assay. Averages and SE bars are shown (n=3). *P<0.05

Back to article page